GCGR and cancer: Knowledge of the molecular mechanism by which KMTs fine-tune GGR activity, and thereby mitigate DNA damage accumulation, cell cycle checkpoints, apoptosis and mutagenesis, will pave the way to the identification of new drug targets and the development of novel therapeutic approaches for the management of cancer and other chronic conditions.